Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model

Cancer Gene Therapy

Volumn 9, Issue 11, 2002, Pages 917-924

  Tyynelä, Kristiina ^a   Sandmair, Anu Maaria ^a   Turunen, Marita ^a   Vanninen, Ritva ^a   Vainio, Pauli ^a   Kauppinen, Risto ^a   Johansson, Risto ^a   Vapalahti, Matti ^a   Ylä Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Gene transfer; Glioma; Macrophage colony stimulating factor; MRI imaging; Thymidine kinase

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; COLONY STIMULATING FACTOR 1; GANCICLOVIR; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER MODEL; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; GENE THERAPY; GENE TRANSFER; GLIOMA; HISTOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; BRAIN NEOPLASMS; DISEASE MODELS, ANIMAL; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; GLIOMA; RATS; RECOMBINANT PROTEINS; SIMPLEXVIRUS; THYMIDINE KINASE; TRANSFECTION;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES; SIMPLEXVIRUS;

EID: 0036841190     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700515     Document Type: Article

References (17)

1. Ammirati M, Galicich JH, Arbit E, Liao Y. Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery. 1987;21:607-614.
2. Salcman M. Supratentorial gliomas: Clinical features and surgical therapy. In: Wilkins RH, Rengachry SS, eds. Neurosurgery. New York: McGraw-Hill, Health Professions Division; 1996:777-788.
3. Culver KW, Ram Z, Walbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumours. Science. 1992;256:1550-1552.
4. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SLC. Gene therapy for brain tumours: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA. 1994;91:3054-3057.
5. Perez-Cruet MJ, Trask TW, Chen SH, et al. Adenovirus-mediated gene therapy of experimental gliomas. J Neurosci Res. 1994;39:506-511.
6. Sandmair A-M, Turunen M, Tyynelä K, et al. Herpes simplex virus thymidine kinase gene therapy in experimental glioma model: Effect of the percentage of thymidine kinase positive glioma cells on the treatment effect, survival time and tissue reactions. Cancer Gene Ther. 2000;7:413-421.
7. Sandmair A-M, Loimas S, Puranen P, et al. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. Hum Gene Ther. 2000;11:2197-2205.
8. Barth RF. Rat brain tumour models in experimental neurooncology: The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neuro-Oncol. 1998;36:91-102.
9. Sandmair A-M, Loimas S, Poptani H, et al. Low efficacy of gene therapy for rat BT4C malignant glioma using transduction with thymidine kinase retrovirus packaging cell injection with ganciclovir treatment. Acta Neurochir. 1999;141:867-872.
10. Ram Z, Culver KW, Oshiro EM, et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med. 1997;3:1354-1361.
11. Barr E, Carroll J, Kalynych AM, et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1994;1:51-58.
12. Rajavashisth TB, Andalibi A, Territo MC, et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature. 1990;344:254-257.
13. Puumalainen A-M, Vapalahti M, Agrawal R, et al. β-Galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum Gene Ther. 1998;9:1769-1774.
14. Paxinos G, Watson C. The Rat Brain in Stereotactic Coordinates. San Diego, CA: Academic Press; 1986 (Plate 22).
15. Klatzmann D, Valéry CA, Bensimon G, et al. A phase I/II study of herpes simplex virus type 1 thymidine kinase "Suicide" gene therapy for recurrent glioblastoma. Hum Gene Ther. 1998;9:2595-2604.
16. Rainov NG. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther. 2000;11:2389-2401.
17. Trask TW, Trask RP, Aguilar-Cordova E, et al. Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with recurrent malignant brain tumors. Mol Ther. 2000;1:195-203.